These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17449118)

  • 1. G418, phleomycin and hygromycin selection of recombinant Trypanosoma brucei parasites refractory to long-term in vitro culture.
    Uzureau P; Felu C; De Muylder G; Pays E; Vanhamme L
    Mol Biochem Parasitol; 2007 Jul; 154(1):90-4. PubMed ID: 17449118
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression site activation in Trypanosoma brucei with three marked variant surface glycoprotein gene expression sites.
    Ulbert S; Chaves I; Borst P
    Mol Biochem Parasitol; 2002 Apr; 120(2):225-35. PubMed ID: 11897128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a compensatory mutant of Leishmania major that lacks ether lipids but exhibits normal growth, and G418 and hygromycin resistance.
    Zufferey R; Bibis SS; Zhu T; Dhalladoo S
    Exp Parasitol; 2012 Mar; 130(3):200-4. PubMed ID: 22306069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an in vivo system to determine the G418 resistance phenotype of bloodstream-form Trypanosoma brucei brucei transfectants.
    Murphy NB; Muthiani AM; Peregrine AS
    Antimicrob Agents Chemother; 1993 May; 37(5):1167-70. PubMed ID: 8517708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating dominant selection markers for Coprinopsis cinerea: a carboxin resistance system and re-evaluation of hygromycin and phleomycin resistance vectors.
    Kilaru S; Collins CM; Hartley AJ; Burns C; Foster GD; Bailey AM
    Curr Genet; 2009 Oct; 55(5):543-50. PubMed ID: 19636558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene disruption in Coccidioides using hygromycin or phleomycin resistance markers.
    Hung CY; Wise HZ; Cole GT
    Methods Mol Biol; 2012; 845():131-47. PubMed ID: 22328372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of filamentous fungi based on hygromycin B and phleomycin resistance markers.
    Punt PJ; van den Hondel CA
    Methods Enzymol; 1992; 216():447-57. PubMed ID: 1479914
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection by drug resistance proteins located in the mitochondria of mammalian cells.
    Yoon YG; Koob MD
    Mitochondrion; 2008 Dec; 8(5-6):345-51. PubMed ID: 18721905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hygromycin B-resistance-encoding gene as a selectable marker for stable transformation of Trypanosoma brucei.
    Lee MG; van der Ploeg LH
    Gene; 1991 Sep; 105(2):255-7. PubMed ID: 1657720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel hygromycin A antibacterial agents.
    Visser MS; Freeman-Cook KD; Brickner SJ; Brighty KE; Le PT; Wade SK; Monahan R; Martinelli GJ; Blair KT; Moore DE
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6730-4. PubMed ID: 20864341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans.
    Hua J; Meyer JD; Lodge JK
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):125-8. PubMed ID: 10618292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of trypanosome artificial mini-chromosomes.
    Lee MG; E Y; Axelrod N
    Nucleic Acids Res; 1995 Dec; 23(23):4893-9. PubMed ID: 8532534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin inhibits interferon-gamma-induced Trypanosoma brucei brucei proliferation: evidence for mevalonate pathway involvement.
    Andersson M; Löw P; Bakhiet M
    J Interferon Cytokine Res; 1996 Jun; 16(6):435-9. PubMed ID: 8807496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds.
    Otoguro K; Ishiyama A; Iwatsuki M; Namatame M; Nishihara-Tukashima A; Nakashima T; Shibahara S; Kondo S; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Sep; 63(9):579-81. PubMed ID: 20588299
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of retroviral mutation rates using spleen necrosis virus-based vectors and helper cells.
    Dougherty JP; Temin HM
    Biotechnology; 1991; 16():21-33. PubMed ID: 2007191
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection of hygromycin-resistant Arabidopsis seedlings.
    Nakazawa M; Matsui M
    Biotechniques; 2003 Jan; 34(1):28-30. PubMed ID: 12545533
    [No Abstract]   [Full Text] [Related]  

  • 17. Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro.
    Gould MK; Schnaufer A
    Antimicrob Agents Chemother; 2014 May; 58(5):2925-8. PubMed ID: 24550326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: sensitivity to selective drugs in phylogenetically unrelated stocks.
    Laurent JP; Swindle J
    Exp Parasitol; 2000 Jan; 94(1):60-1. PubMed ID: 10631084
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiprotozoal activities of new bis-chlorophenyl derivatives of bicyclic octanes and aza-nonanes.
    Berger H; Seebacher W; Saf R; Kaiser M; Brun R; Weis R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5457-61. PubMed ID: 16889962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.